Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
DEAR MAYO CLINIC: I've been struggling with back stiffness and pain for a long time, but it has gotten worse in the last few years. My doctor told me that I have degenerative disk disease. What ...
DEAR MAYO CLINIC: I've been struggling with back stiffness and pain for a long time, but it has gotten worse in the last few years. My doctor told me that I have degenerative disk disease. What ...
Interventional pain specialists warn spring activity aggravates back conditions and share how innovative regenerative ...
New peer-reviewed study highlights safety and clinical benefits of intradiscal MSC therapy for chronic low back pain ...